Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'phase II study' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 179 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wagenaar, HC; Pecorelli, S; Mangioni, C; van der Burg, MEL; Rotmensz, N; Anastasopoulou, A; Zola, P; Veenhof, CHN; Lacave, AJ; Neijt, JP; van Oosterom, AT; Einhorn, N; Vermorken, JB
      Phase II study of mitomycin-C and cisplatin in disseminated, squamous cellcarcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

      EUROPEAN JOURNAL OF CANCER
    2. Hauns, B; Haring, B; Kohler, S; Mross, K; Unger, C
      Phase II study of combined 5-fluorouracil/Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer

      PHYTOTHERAPY RESEARCH
    3. Oudard, S; Caty, A; Humblet, Y; Beauduin, M; Suc, E; Piccart, M; Rolland, F; Fumoleau, P; Bugat, R; Houyau, P; Monnier, A; Sun, X; Montcuquet, P; Breza, J; Novak, J; Gil, T; Chopin, D
      Phase II study of vinorelbine in patients with androgen-independent prostate cancer

      ANNALS OF ONCOLOGY
    4. Lorenz, M; Mueller, HH; Mattes, E; Gassel, HJ; Junginger, T; Saeger, HD; Schramm, H; Staib-Sebler, E; Vetter, G; Heinrich, S; Kohne, CH
      Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas

      ANNALS OF ONCOLOGY
    5. Peiffert, D; Giovannini, M; Ducreux, M; Michel, P; Francois, E; Lemanski, C; Mirabel, X; Cvitkovic, F; Luporsi, E; Conroy, T; Gerard, JP
      High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

      ANNALS OF ONCOLOGY
    6. Hartung, G; Hofheinz, RD; Wein, A; Riedel, C; Rost, A; Fritze, D; Kreuser, ED; Drees, M; Kuhnel, J; Hehlmann, R; Queisser, W
      Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer

      ONKOLOGIE
    7. Hayashi, K; Ando, N; Watanabe, H; Ide, H; Nagai, K; Aoyama, N; Takiyama, W; Ishida, K; Isono, K; Makuuchi, H; Imamura, M; Shinoda, M; Ikeuchi, S; Kabuto, T; Yamana, H; Fukuda, H
      Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracilin advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) trial (JCOG9407)

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    8. Bellott, R; Auvrignon, A; Leblanc, T; Perel, Y; Gandemer, V; Bertrand, Y; Mechinaud, F; Bellenger, P; Vernois, J; Leverger, G; Baruchel, A; Robert, J
      Pharmacokinetics of liposomal daunorubicin [DaunoXome] during a phase I-IIstudy in children with relapsed acute lymphoblastic leukaemia

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. Murphy, RL; Brun, S; Hicks, C; Eron, JT; Gulick, R; King, M; White, AC; Benson, C; Thompson, M; Kessler, HA; Hammer, S; Bertz, R; Hsu, A; Japour, A; Sun, E
      ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

      AIDS
    10. Gridelli, C; Cigolari, S; Gallo, C; Manzione, L; Ianniello, GP; Frontini, L; Ferrau, F; Robbiati, SF; Adamo, V; Gasparini, G; Novello, S; Perrone, F
      Activity and toxicity of gemcitabine and gemcitabine plus vinorelbine in advanced non-small-cell lung cancer elderly patients - Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial

      LUNG CANCER
    11. Kim, WS; Kim, MM; Choi, HJ; Yoon, SS; Lee, MH; Park, K; Park, CH; Kang, WK
      Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma

      INVESTIGATIONAL NEW DRUGS
    12. Mariani, G; Tagliabue, P; Zucchinelli, P; Brambilla, C; Demicheli, R; Villa, E; Marchiano, A; Valagussa, P; Bonadonna, G; Gianni, L
      Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    13. Bell, BA; Chang, MN; Weinstein, HJ
      A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study

      MEDICAL AND PEDIATRIC ONCOLOGY
    14. Clark, JI; Hofmeister, C; Choudhury, A; Matz, G; Collins, S; Bastian, R; Melian, E; Emami, B; Petruzzelli, G
      Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma

      CANCER
    15. Calvo, E; Cortes, J; Rodriguez, J; Sureda, M; Beltran, U; Rebollo, J; Martinez-Monge, R; Berian, JM; de Irala, J; Brugarolas, A
      Fixed higher dose schedule of suramin plus hydrocortisone in patients withhormone refractory prostate carcinoma - A multicenter phase II study

      CANCER
    16. Hirsh, V; Langleben, A; Ayoub, J; Cormier, Y; Pintos, J; Iglesias, JL
      Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma - A phase II multicenter trial

      CANCER
    17. Scheithauer, W; Kornek, GV; Ulrich-Pur, H; Penz, M; Raderer, M; Salek, T; Haider, K; Kwasny, W; Depisch, D
      Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial

      CANCER
    18. Ueoka, H; Tanimoto, M; Kiura, K; Tabata, M; Takigawa, N; Segawa, Y; Takata, I; Eguchi, K; Okimoto, N; Harita, S; Kamei, H; Shibayama, T; Watanabe, Y; Hiraki, S; Harada, M
      Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

      BRITISH JOURNAL OF CANCER
    19. Janinis, J; Efstathiou, E; Panopoulos, C; Samantas, E; Aravantinos, G; Christodoulou, C; Skarlos, D
      Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status

      MEDICAL ONCOLOGY
    20. Mermershtain, W; Lavrenkov, K; Cohen, Y
      Phase II study of weekly high dose fluorouracil in previously treated patients with metastatic colorectal cancer

      JOURNAL OF CHEMOTHERAPY
    21. Mulne, AF; Ducore, JM; Elterman, RD; Friedman, HS; Krischer, JP; Kun, LE; Shuster, JJ; Kadota, RP
      Oral methotrexate for recurrent brain tumors in children: A Pediatric Oncology Group Study

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    22. Gahn, B; Brittinger, G; Dolken, G; Dohner, H; Emmerich, B; Franke, A; Freund, M; Huber, C; Kuse, R; Scholten, T; Hiddemann, W
      Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia

      LEUKEMIA & LYMPHOMA
    23. Takahashi, Y; Mai, M; Taguchi, T; Urushizaki, I; Nishioka, K
      Prolonged stable disease effects survival in patients with solid gastric tumor: Analysis of phase II studies of doxifluridine

      INTERNATIONAL JOURNAL OF ONCOLOGY
    24. Warde, P; Kroll, B; O'Sullivan, B; Aslanidis, J; Tew-George, E; Waldron, J; Maxymiw, W; Liu, FF; Payne, D; Cummings, B
      A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer

      SUPPORTIVE CARE IN CANCER
    25. Sugimachi, K; Maehara, Y
      A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    26. Feuring-Buske, M; Kneba, M; Unterhalt, M; Engert, A; Gramatzki, M; Hiller, E; Trumper, L; Brugger, W; Ostermann, H; Atzpodien, J; Hallek, M; Aulitzky, E; Hiddemann, W
      IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group

      ANNALS OF HEMATOLOGY
    27. Comella, P; De Vita, F; Mancarella, S; De Lucia, L; Biglietto, M; Casaretti, R; Farris, A; Ianniello, GP; Lorusso, V; Avallone, A; Carteni, G; Leo, S; Catalano, G; De Lena, M; Comella, G
      Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: A Southern Italy Cooperative Oncology Group phase II-III randomized trial

      ANNALS OF ONCOLOGY
    28. Takenaka, T; Mikuni, C; Miura, A; Sasaki, T; Suzuki, H; Hotta, T; Hirano, M; Fukuhara, S; Sugiyama, H; Nasu, K; Dohi, H; Kozuru, M; Tomonaga, M; Tajima, K; Niimi, M; Fukuda, H; Mukai, K; Shimoyama, M
      Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905)

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    29. Fujita, A; Takabatake, H; Tagaki, S; Sekine, K
      Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    30. Rosati, G; Riccardi, F; Tucci, A; De Rosa, P; Pacilio, G
      A phase II study of paclitaxel/cisplatin combination in patients with metastatic breast cancer refractory to anthracycline-based chemotherapy

      TUMORI
    31. Illiano, A; Barletta, E; De Marino, V; Battiloro, C; Barzelloni, M; Scognamiglio, F; Rossi, N; Zampa, G; De Bellis, M; Gridelli, C
      New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase II study

      ANTICANCER RESEARCH
    32. Gridelli, C; Frontini, L; Barletta, E; Rossi, A; Barzelloni, ML; Scognamiglio, F; Guida, C; Gatani, T; Fiore, F; De Bellis, M; Marfella, A; Manzione, L
      Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature

      ANTICANCER RESEARCH
    33. Eggermont, AMM; van IJken, MGA; van Etten, B; van der Sijp, JRM; ten Hagen, TLM; Wiggers, T; Oudkerk, M; de Boeck, G; de Bruijn, EA
      Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: From laboratory to the clinic towards a percutaneous procedure

      HEPATO-GASTROENTEROLOGY
    34. Beppu, T; Yoshida, Y; Arai, H; Wada, T; Suzuki, M; Ogawa, A; Hakozaki, S; Kubo, N
      A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas

      JOURNAL OF NEURO-ONCOLOGY
    35. Kuratsu, J; Arita, N; Kayama, T; Kubo, N; Mori, T; Sawamura, Y; Ushio, Y
      Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients

      JOURNAL OF NEURO-ONCOLOGY
    36. Lencioni, M; Falcone, A; Allegrini, G; Pfanner, E; Masi, G; Brunetti, I; Di Marsico, R; Fontana, E; Orlandini, C; Stampino, CG; Bartolozzi, C; Conte, PF
      Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study

      ONCOLOGY
    37. Koizumi, W; Kurihara, M; Nakano, S; Hasegawa, K
      Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer

      ONCOLOGY
    38. Rodriguez, J; Cortes, J; Calvo, E; Azinovic, I; Fernandez-Hildago, O; Martinez-Monge, R; Garzon, C; de Irala, J; Martinez-Aguillo, M; Cajal, TRY; Brugarolas, A
      Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma - A Phase II study

      CANCER
    39. Eton, O; Buzaid, AC; Bedikian, AY; Smith, TM; Papadopoulos, NE; Ellerhorst, JA; Hibberts, JL; Legha, SS; Benjamin, RS
      A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

      CANCER
    40. Buccheri, G; Ferrigno, D
      Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma - A Phase II study

      CANCER
    41. Matano, E; Tagliaferri, P; Libroia, A; Damiano, V; Fabbrocini, A; De Lorenzo, S; Bianco, AR
      Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study

      BRITISH JOURNAL OF CANCER
    42. Yamamoto, K; Yajima, A; Terashima, Y; Nozawa, S; Taketani, Y; Yakushiji, M; Noda, K
      Phase II clinical study on the effects of recombinant human interleukin-3 on thrombocytopenia after chemotherapy for advanced ovarian cancer

      JOURNAL OF IMMUNOTHERAPY
    43. Vey, N; Blaise, D; Lafage, M; Olive, D; Viens, P; Baume, D; Camerlo, J; Stoppa, AM; Gabus, R; Brandely, M; Hercend, T; Maraninchi, D
      Treatment of chronic myelogenous leukemia with interleukin-2: A phase II study in 21 patients

      JOURNAL OF IMMUNOTHERAPY
    44. Kadota, RP; Kun, LE; Langston, JW; Burger, PC; Cohen, ME; Mahoney, DH; Walter, AW; Rodman, JH; Parent, A; Buckley, E; Kepner, JL; Friedman, HS
      Cyclophosphamide for the treatment of progressive low-grade astrocytoma: Apediatric oncology group phase II study

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    45. Koizumi, W; Tanabe, S; Kurihara, M; Kondou, I; Yamazaki, I; Saigenji, K
      Pilot study of combined treatment with continuous infusion of 5-fluorouracil, mitomycin C, and cisplatin (FMP) in patients with inoperable advanced gastric cancer

      ONCOLOGY REPORTS
    46. von der Maase, H; Andersen, L; Crino, L; Weinknecht, S; Dogliotti, L
      Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial

      ANNALS OF ONCOLOGY
    47. Drevs, J; Droll, A; Mross, K; Unger, C
      Angiogenesis inhibition: Drugs in clinical trials

      ONKOLOGIE
    48. Takenaka, T; Shirakawa, S; Mikuni, C; Sai, T; Shimamoto, Y; Araki, K; Hirano, M; Miura, A; Ohno, Y; Ichimaru, M; Hanada, S; Inaba, S; Konishi, H; Toki, H; Tajima, K; Niimi, M; Fukuda, H; Shimoyama, M
      Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906)

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    49. Ikeda, T; Adachi, I; Takashima, S; Ogita, M; Aoyama, H; Sano, M; Ando, J; Tabei, T; Tominaga, T; Enomoto, K; Kanda, K; Fukutomi, T; Shimoyama, M
      A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer:A Japan Clinical Oncology Group (JCOG) Study 9113

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    50. Mori, K; Machida, S; Yoshida, T; Yoshida, M; Kano, Y; Tominaga, K
      A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    51. Goedhals, L; Vorobiof, DA; Bezwoda, W; Van Merwe, A; Jordaan, JP; Barnardt, P; Smith, BL
      Phase II trial of i.v. vinorelbine and cisplatin in inoperable locally advanced or disseminated nonsmall-cell lung cancer: The South African experience

      CURRENT MEDICAL RESEARCH AND OPINION
    52. Pazdur, R; Royce, ME; Rodriguez, GI; Rinaldi, DA; Patt, YZ; Hoff, PM; Burris, HA
      Phase trial of docetaxel for cholangiocarcinoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    53. Gridelli, C; Perrone, F; Gallo, C; Rossi, A; Barletta, E; Barzelloni, ML; Creazzola, S; Gatani, T; Fiore, F; Guida, C; Scognamiglio, F
      Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial

      ANTICANCER RESEARCH
    54. Fujiwara, K; Kohno, I; Tanaka, K; Ogita, S; Sasaki, Y; Hirabayashi, K; Yakushiji, M; Tsunematsu, R; Terashima, Y; Taguchi, T; Ohashi, Y; Noda, K
      Phase II dose escalation: A novel approach to balancing efficacy and toxicity of anticancer agents

      ANTICANCER RESEARCH
    55. Prior, C; Oroszy, S; Oberaigner, W; Ambrosch, G; Mohn-Staudner, A; Pfeifer, W; Pirker, R; Huber, H
      Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    56. Huinink, WWT; Bergman, B; Chemaissani, A; Dornoff, W; Drings, P; Kellokumpu-Lehtinen, PL; Liippo, K; Mattson, K; von Pawel, J; Ricci, S; Sederholm, C; Stahel, RA; Wagenius, G; von Walree, N; Manegold, C
      Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

      LUNG CANCER
    57. Andersen, MK; Krarup-Hansen, A; Martensson, G; Winther-Nielsen, H; Thylen, A; Damgaard, K; Olling, S; Wallin, J
      Ifosfamide in malignant mesothelioma: a phase II study

      LUNG CANCER
    58. Kuratsu, J; Arita, N; Kurisu, K; Uozumi, T; Hayakawa, T; Ushio, Y
      A phase II study of KRN8602(MX2), a novel morpholino anthracycline derivative, in patients with recurrent malignant glioma

      JOURNAL OF NEURO-ONCOLOGY
    59. Sugimachi, K; Maehara, Y; Horikoshi, N; Shimada, Y; Sakata, Y; Mitachi, Y; Taguchi, T
      An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers

      ONCOLOGY
    60. Kim, NK; Im, SA; Kim, DW; Lee, MH; Jung, CW; Cho, EK; Lee, JT; Ahn, JS; Heo, DS; Bang, YJ
      Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma

      CANCER
    61. Ramanathan, RK; Lipsitz, S; Asbury, RF; Qazi, R; Greenberg, BR; Haller, DG
      Phase II trial of trimetrexate for patients with advanced gastric carcinoma - An Eastern Cooperative Oncology Group Study (E1287)

      CANCER
    62. Sweeney, CJ; Williams, SD; Finch, DE; Bihrle, R; Foster, RS; Collins, M; Fox, S; Roth, BJ
      A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium

      CANCER
    63. van Meerbeeck, JP; Bass, P; Debruyne, C; Groen, HJ; Manegold, C; Ardizzoni, A; Gridelli, C; van Marck, EA; Lentz, M; Giaccone, G
      A phase II study of gemcitabine in patients with malignant pleural mesothelioma

      CANCER
    64. Ardizzoni, A; Grossi, F; Scolaro, T; Giudici, S; Foppiano, F; Boni, L; Tixi, L; Cosso, M; Mereu, C; Ratto, GB; Vitale, V; Rosso, R
      Induction chemotherapy followed by concurrent standard radiotherapy and daily low dose cisplatin in locally advanced non-small-cell lung cancer

      BRITISH JOURNAL OF CANCER
    65. Okada, S; Sakata, Y; Matsuno, S; Kurihara, M; Sasaki, Y; Ohashi, Y; Taguchi, T
      Phase II study of docetaxel in patients with metastatic pancreatic cancer:a Japanese cooperative study

      BRITISH JOURNAL OF CANCER
    66. Hauns, B; Haring, B; Kohler, S; Mross, K; Robben-Bathe, P; Unger, C
      Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC)in patients with pancreatic cancer

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    67. NITSCHKE R; PARKHURST J; SULLIVAN J; HARRIS MB; BERNSTEIN M; PRATT C
      TOPOTECAN IN PEDIATRIC-PATIENTS WITH RECURRENT AND PROGRESSIVE SOLID TUMORS - A PEDIATRIC-ONCOLOGY-GROUP PHASE-II STUDY

      Journal of pediatric hematology/oncology
    68. MANTOVANI G; GHIANI M; LAI P; MACCIO A; DESSI D; SUCCU G; MASSA D; CURRELI L; MULAS C; ESU S; PROTO E; CADEDDU G; TORE G
      CLINICAL-EVALUATION OF 2 DOSAGES AND SCHEDULES OF IFOSFAMIDE IN COMBINATION WITH CISPLATIN IN NEOADJUVANT CHEMOTHERAPY OF PATIENTS WITH ADVANCED (STAGE III-IV) HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PHASE-II RANDOMIZED STUDY

      Oncology Reports
    69. CHEUNG NKV; KUSHNER BH; YEH SDJ; LARSON SM
      3F8 MONOCLONAL-ANTIBODY TREATMENT OF PATIENTS WITH STAGE-4 NEUROBLASTOMA - A PHASE-II STUDY

      International journal of oncology
    70. Le Chevalier, T; Monnier, A; Douillard, JY; Ruffie, P; Sun, XS; Belli, L; Ibrahim, N; Bougon, N; Berille, J
      Docetaxel (Taxotere((R))) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    71. DEGARDIN M; OLIVEIRA J; GEOFFROIS L; ROLLAND F; ARMAND JP; BASTIT P; CHAUVERGNE J; FARGEOT P; VANGLABBEKE M; LENTZ MA; TRESCA P; BOUDILLET J; FUMOLEAU P; CAPPELAERE P
      AN EORTC-ECSG PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/

      Annals of oncology
    72. DIAZRUBIO E; SASTRE J; ZANIBONI A; LABIANCA R; CORTESFUNES H; DEBRAUD F; BONI C; BENAVIDES M; DALLAVALLE G; HOMERIN M
      OXALIPLATIN AS SINGLE-AGENT IN PREVIOUSLY UNTREATED COLORECTAL-CARCINOMA PATIENTS - A PHASE-II MULTICENTRIC STUDY

      Annals of oncology
    73. Andre, T; Louvet, C; Raymond, E; Tournigand, C; de Gramont, A
      Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen

      ANNALS OF ONCOLOGY
    74. von Minckwitz, G; Costa, SD; Loibl, S; Caminada, MC; Kaufmann, M
      Combination of docetaxel and mitoxantrone for the therapy of metastatic breast cancer - a phase I-II study

      TUMORDIAGNOSTIK & THERAPIE
    75. Luck, HJ; Scholz, U; Petry, KU; Bohmer, G; Kuhnle, H
      Importance of topotecan in the therapy of ovarian carcinoma, today and tomorrow

      ONKOLOGIE
    76. ZAMAGNI C; MARTONI A; CACCIARI N; GENTILE A; PANNUTI F
      THE COMBINATION OF PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH STAGE-III AND STAGE IV OVARIAN-CANCER - A PHASE I-II STUDY

      American journal of clinical oncology
    77. OHTSU A; BOKU N; TAMURA F; MURO K; SHIMADA Y; SAIGENJI K; AKAZAWA S; KITAJIMA M; KANAMARU R; TAGUCHI T
      AN EARLY PHASE-II STUDY OF A 3-HOUR INFUSION OF PACLITAXEL FOR ADVANCED GASTRIC-CANCER

      American journal of clinical oncology
    78. COLLICHIO FA; PANDYA K
      INTERFERON-ALPHA-2B AND MEGESTROL-ACETATE IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY

      American journal of clinical oncology
    79. CSATARY LK; TELEGDY L; GERGELY P; BODEY B; BAKACS T
      PRELIMINARY-REPORT OF A CONTROLLED TRIAL OF MTH-68 B(TM) VIRUS-VACCINE TREATMENT IN ACUTE B-HEPATITIS AND C-HEPATITIS - A PHASE-II STUDY/

      Anticancer research
    80. Zatloukal, P; Kanitz, E; Magyar, P; Jassem, J; Krzakowski, M; Pawlicki, M; Petruzelka, L; Chovan, L; Pesek, M; Janko, C; Krejcy, K
      Gemcitabine in locally advanced and metastatic non-small cell lung cancer:The Central European phase II study

      LUNG CANCER
    81. MAURER CA; BORNER MM; LAUFFER J; FRIESS H; ZGRAGGEN K; TRILLER J; BUCHLER MW
      CELIAC AXIS INFUSION CHEMOTHERAPY IN ADVANCED NONRESECTABLE PANCREATIC-CANCER

      International journal of pancreatology
    82. ITO Y; HORIKOSHI N; WATANABE T; SASAKI Y; TOMINAGA T; OKAWA T; TABEI T; KURAISHI Y; TAMURA K; ABE R; KITAJIMA M; YAMAGUCHI S; KOBAYASHI T; KOYAMA H; ORITA K; TAKASHIMA S; NOMURA Y; OGAWA M
      PHASE-II STUDY OF PACLITAXEL (BMS-181339) INTRAVENOUSLY INFUSED OVER 3 HOURS FOR ADVANCED OR METASTATIC BREAST-CANCER IN JAPAN

      Investigational new drugs
    83. Latreille, J; Gelmon, KA; Hirsh, V; Laberge, F; Maksymiuk, AW; Shepherd, FA; Delorme, F; Berille, J
      Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience

      INVESTIGATIONAL NEW DRUGS
    84. TORTORIELLO A; FACCHINI G; CAPONIGRO F; SANTANGELO M; BENASSAI G; PERSICO G; CITARELLA A; CAROLA M; MARZANO N; IAFFAIOLI RV
      PHASE I II STUDY OF PACLITAXEL AND VINORELBINE IN METASTATIC BREAST-CANCER/

      Breast cancer research and treatment
    85. SAMUELS BL; HERNDON JE; HARMON DC; CAREY R; AISNER J; CORSON JM; SUZUKI Y; GREEN MR; VOGELZANG NJ
      DIHYDRO-5-AZACYTIDINE AND CISPLATIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMA - A PHASE-II STUDY BY THE CANCER AND LEUKEMIA GROUP-B

      Cancer
    86. BALDINI E; TIBALDI C; ARDIZZONI A; SALVATI F; ANTILLI A; PORTALONE L; BARBERA S; ROMANO F; DEMARINIS F; MIGLIORINO MR; NOSEDA MA; BORGHINI U; CRIPPA M; FERRARA G; RAIMONDI M; FIORETTI M; BANDERA M; PENNUCCI MC; GALEASSO G; CACCIANI GC; LEPIDINI G; SUNSERI G; LANFRANCO C; RINALDI M; LIONETTO R; CONTE PF; ROSSO R
      CISPLATIN-VINDESINE-MITOMYCIN (MVP) VS CISPLATIN-IFOSFAMIDE-VINORELBINE (PIN) VS CARBOPLATIN-VINORELBINE (CAN) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) - A FONICAP RANDOMIZED PHASE-II STUDY

      British Journal of Cancer
    87. BAKKER M; DROZ JP; HANAUSKE AR; VERWEIJ J; VANOOSTEROM AT; GROEN HJM; PACCIARINI MA; DOMENIGONI L; VANWEISSENBRUCH F; PIANEZZOLA E; DEVRIES EGE
      BROAD PHASE-II AND PHARMACOKINETIC STUDY OF METHOXY-MORPHOLINO DOXORUBICIN (FCE 23762-MMRDX) IN NON-SMALL-CELL LUNG-CANCER, RENAL-CANCER AND OTHER SOLID TUMOR PATIENTS

      British Journal of Cancer
    88. PERDU M; CAMUS E; ROZENBERG P; GOFFINET F; CHASTANG C; PHILIPPE HJ; NISAND I
      TREATING ECTOPIC PREGNANCY WITH THE COMBINATION OF MIFEPRISTONE AND METHOTREXATE - A PHASE-II NONRANDOMIZED STUDY

      American journal of obstetrics and gynecology
    89. TUXEN MK; LUND B; HANSEN OP; BERTELSEN K; HANSEN M
      ORAL ETOPOSIDE IN ELDERLY PREVIOUSLY UNTREATED OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE

      International journal of gynecological cancer
    90. NASTASI G; PORTA C; MORONI M; ALESSIANI M; FOSSATI G
      INTRAHEPATIC FLUORODEOXYURIDINE TO TREAT UNRESECTABLE HEPATOCELLULAR-CARCINOMA PATIENTS

      Oncology Reports
    91. PAWINSKI A; VANOOSTEROM AT; DEWIT R; FOSSA S; CROLES J; SVEDBERG A; LENTZ MA; DEMULDER PHM
      AN EORTC PHASE-II STUDY OF THE EFFICACY AND SAFETY OF LINOMIDE IN THETREATMENT OF ADVANCED RENAL-CELL CARCINOMA

      European journal of cancer
    92. BOBBIOPALLAVICINI E; PORTA C; MORONI M; BERTULEZZI G; CIVELLI L; PUGLIESE P; NASTASI G
      EPIRUBICIN AND ETOPOSIDE COMBINATION CHEMOTHERAPY TO TREAT HEPATOCELLULAR-CARCINOMA PATIENTS - A PHASE-II STUDY

      European journal of cancer
    93. PLANTING AST; DEMULDER PHM; DEGRAEFF A; VERWEIJ J
      PHASE-II STUDY OF WEEKLY HIGH-DOSE CISPLATIN FOR 6 CYCLES IN PATIENTSWITH LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      European journal of cancer
    94. YOKOYAMA A; NAKAI Y; YONEDA S; KURITA Y; NIITANI H
      ACTIVITY OF GEMCITABINE IN THE TREATMENT OF PATIENTS WITH NONSMALL CELL LUNG-CANCER - A MULTICENTER PHASE-II STUDY

      Anti-cancer drugs
    95. MANEGOLD C; BERGMAN B; CHEMAISSANI A; DORNOFF W; DRINGS P; KELLOKUMPULEHTINEN P; LIIPPO K; MATTSON K; VONPAWEL J; RICCI S; SEDERHOLM C; STAHEL RA; WAGENIUS G; VONWALREE N; TENBOKKELHUININK W
      SINGLE-AGENT GEMCITABINE VERSUS CISPLATIN-ETOPOSIDE - EARLY RESULTS OF A RANDOMIZED PHASE-II STUDY IN LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG-CANCER

      Annals of oncology
    96. PEIFFERT D; SEITZ JF; ROUGIER P; FRANCOIS E; CVITKOVIC F; MIRABEL X; NASCA S; DUCREUX M; HANNOUNLEVI JM; LUSINCHI A; DEBRIGODE E; CONROY T; PIGNON JP; GERARD JP
      PRELIMINARY-RESULTS OF A PHASE-II STUDY OF HIGH-DOSE RADIATION-THERAPY AND NEOADJUVANT PLUS CONCOMITANT 5-FLUOROURACIL WITH CDDP CHEMOTHERAPY FOR PATIENTS WITH ANAL-CANAL CANCER - A FRENCH COOPERATIVE STUDY

      Annals of oncology
    97. SIMMONDS PD; MEAD GM; SWEETENHAM JW; OCALLAGHAN A; SMARTT P; KERR J; HAMILTON CR; GOLDING PF; MILNE AE; WHITEHOUSE JMA
      PACE BOM CHEMOTHERAPY - A 12-WEEK REGIMEN FOR ADVANCED HODGKINS-DISEASE

      Annals of oncology
    98. NEUENDANK A; HARTMANN R; BUHRER C; WINTERHALTER B; KLUMPER E; VEERMAN AJP; HENZE G
      ACUTE TOXICITY AND EFFECTIVENESS OF IDARUBICIN IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA

      European journal of haematology
    99. DONADIEU J; BOUTARD P; BERNATOWSKA E; TCHERNIA G; COUILLAUD G; PHILIPPE N; LEGALL E
      A EUROPEAN PHASE-II STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (LENOGRASTIM) IN THE TREATMENT OF SEVERE CHRONIC NEUTROPENIA IN CHILDREN

      European journal of pediatrics
    100. SALTZ LB; SCHWARTZ GK; ILSON DH; QUAN V; KELSEN DP
      A PHASE-II STUDY OF TOPOTECAN ADMINISTERED 5 TIMES DAILY IN PATIENTS WITH ADVANCED GASTRIC-CANCER

      American journal of clinical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 23:07:12